HealthCentre Caps Trade Margins on Non-Scheduled Cancer Drugs at 30% MRP
The Union government has decided to cap trade margins on all non-scheduled anti-cancer drugs at 30% of the maximum retail price (MRP) to make cancer treatment more affordable. This applies to branded, generic, domestic, imported, patented, and non-patented medicines. An expert committee under DGHS will finalize the list. NPPA found average mark-ups around 170%, sometimes reaching 700%, with price variations across retail, hospital, and online pharmacies.
Hindu Health··New Delhi

